Voyageur Pharmaceuticals plans to settle $192,300 of debt by issuing common shares priced at $0.155 each, the closing price on September 24, 2026. This includes $52,300 owed to an officer for consulting fees and $140,000 to other creditors, helping the company conserve cash. The shares issued will be subject to a four-month and one-day hold period, pending regulatory approvals. Voyageur aims to strengthen its position in the pharmaceutical-grade barium and iodine contrast media market by vertically integrating production and transitioning into a high-margin domestic manufacturer of radiology drugs.
Voyageur Pharmaceuticals plans to issue shares to settle $192,300 in debt, with shares priced at $0.155 each as of September 24, 2026. For readers following the health sector, here is Pluang's market snapshot as of Sep 25, 2026 04:41 WIB: out of 100 priced US health stocks, 38 rose and 62 fell. Notable movers include FLNA at USD 0.86 with a 16.15% decline and a typical hold time of 37 days, ACAD at USD 22.36 down 12.07% with a 76-day hold, and TXG at USD 84.70 up 12.01% with a 94-day hold.
TD SYNNEX posted a record-breaking quarter in Q3 2026 with earnings and revenue surpassing expectations, driven by strong growth in its Hyve Solutions segment and AI infrastructure demand. Despite this, the stock dropped nearly 9% due to a nearly $1 ...
A crypto whale transferred 6,000 Ether (ETH), worth approximately $16.1 million, to five major cryptocurrency exchanges: OKX, Kraken, Gate, Bybit, and Binance. This large transfer places a significant amount of ETH on trading platforms, suggesting th...
Warren Buffett increased his stake in homebuilder Lennar to over 10% immediately after the company missed earnings and lowered its full-year delivery forecast. Despite Lennar's recent weak quarter, Buffett's move signals confidence in the long-term h...
TRON has exceeded $30 trillion in total transaction volume, marking its evolution into a high-throughput settlement network. Daily transactions exceed $30 billion, supported by over 405 million users and 15.6 billion processed transactions, mainly dr...
Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...
